CVRx announced certain preliminary unaudited fourth quarter and full year 2022 revenue results, and provided a 2023 business outlook. Fourth Quarter 2022: Total revenue for the fourth quarter of 2022 is expected to be in the range of approximately $7.0 million to $7.1 million, representing an increase of approximately 91% to 94% over fourth quarter 2021 revenue of $3.66 million. Total revenue generated in the fourth quarter of 2022 is expected to be made up of approximately $5.9 million in U.S. heart failure revenue, $1.2 million in European revenue and $26,000 in U.S. legacy revenue.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CVRX:
